does glp 1 help binge eating disorder The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward GLP-1 therapy appears to reduce

This is usually due to their impact on gastric motility, leading to a slowdown in digestion

Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Superoxide dismutase is an enzyme that neutralizes free radicals

Generally, you may qualify with a BMI of 30+ or BMI 27+ if you have a weight-related condition like high blood pressure, type 2 diabetes, or sleep apnea

AACE Clinical Case Reports

Providers evaluate each patients health history, goals, and lifestyle before recommending treatment options